The goal of this study was to analyze case study data that suggests the value of adding CA11-19 to monitoring patients at risk of recurrence of colorectal cancer.
- EDP Biotech Re-Certified for ISO 13485 Compliance
- Online video and print article present ColoMarker study results by BF Overholt MD
- CA11-19 Monitoring data presented at Gastrointestinal Cancer Symposia (Poster)
- EDP Biotech Achieves ISO 13485 Certification
- Journal of Gastrointestinal Endoscopy Published Trial Results